Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome

[1]  E. Owiredu,et al.  Demographic and Lifestyle Predictors of Prehypertension: A Cross-Sectional Study among Apparently Healthy Adults in Kumasi, Ghana , 2019, BioMed research international.

[2]  M. Kasum,et al.  Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[3]  R. Azziz,et al.  The pressing need for standardization in epidemiologic studies of PCOS across the globe , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  S. Bhattacharya,et al.  Obesity and fertility , 2015, Hormone molecular biology and clinical investigation.

[5]  W. Almawi,et al.  Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome. , 2015, Fertility and sterility.

[6]  B. Dunphy,et al.  Female obesity and infertility. , 2015, Best practice & research. Clinical obstetrics & gynaecology.

[7]  Sewon Lee,et al.  Role of adiponectin in metabolic and cardiovascular disease , 2014, Journal of exercise rehabilitation.

[8]  Rita V Weiss,et al.  Female infertility of endocrine origin. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[9]  Haiming Cao.  Adipocytokines in obesity and metabolic disease. , 2014, The Journal of endocrinology.

[10]  Jun Ren,et al.  What fans the fire: insights into mechanisms of leptin in metabolic syndrome-associated heart diseases. , 2014, Current pharmaceutical design.

[11]  S. Franks,et al.  Adipocyte biology in polycystic ovary syndrome , 2013, Molecular and Cellular Endocrinology.

[12]  P. Spritzer,et al.  Association between adipose tissue expression and serum levels of leptin and adiponectin in women with polycystic ovary syndrome. , 2013, Genetics and molecular research : GMR.

[13]  M. Christiansen,et al.  Adipose expression of adipocytokines in women with polycystic ovary syndrome. , 2012, Fertility and sterility.

[14]  S. Heymsfield,et al.  The body adiposity index (hip circumference ÷ height1.5) is not a more accurate measure of adiposity than is BMI, waist circumference, or hip circumference , 2012, Obesity.

[15]  K. Gumaa,et al.  Leptin-to-adiponectin, adiponectin-to-leptin ratios, and insulin are specific and sensitive markers associated with polycystic ovary syndrome: a case-control study from Bahrain. , 2012, Metabolic syndrome and related disorders.

[16]  R. Sherwood,et al.  Leptin/adiponectin ratio in patients with coronary heart disease: comparing subjects with and without metabolic syndrome , 2011, Annals of clinical biochemistry.

[17]  P. Spritzer,et al.  Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome. , 2011, Fertility and sterility.

[18]  L. Lönn,et al.  Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. , 2011, The Journal of clinical endocrinology and metabolism.

[19]  A. Malamitsi‐Puchner,et al.  Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. , 2010, Fertility and sterility.

[20]  Won-Young Lee,et al.  The Relationship of Adiponectin/Leptin Ratio with Homeostasis Model Assessment Insulin Resistance Index and Metabolic Syndrome in Apparently Healthy Korean Male Adults , 2010, Korean diabetes journal.

[21]  G. Colditz,et al.  Obesity and Cancer , 2010, The oncologist.

[22]  B. Mol,et al.  Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care. , 2010, Human reproduction update.

[23]  M. Bahçeci,et al.  Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[24]  S. Gay,et al.  The role of resistin as a regulator of inflammation: Implications for various human pathologies. , 2009, Clinical immunology.

[25]  J. R. L. D. Mola,et al.  Obesity and its relationship to infertility in men and women. , 2009 .

[26]  G. Rini,et al.  Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. , 2009, Fertility and sterility.

[27]  V. Bordignon,et al.  The ‘beneficial’ adipokines in reproduction and fertility , 2008, International Journal of Obesity.

[28]  R. Pasquali,et al.  Obesity and infertility , 2007, Current opinion in endocrinology, diabetes, and obesity.

[29]  P. Magni,et al.  Leptin:Adiponectin Ratio Is an Independent Predictor of Intima Media Thickness of the Common Carotid Artery , 2007, Stroke.

[30]  N. Abdella,et al.  Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes , 2007, International Journal of Obesity.

[31]  Donald D Hensrud,et al.  Extreme obesity: a new medical crisis in the United States. , 2006, Mayo Clinic proceedings.

[32]  J. L. San Millán,et al.  Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. , 2006, Human reproduction.

[33]  C. Simón,et al.  Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. , 2006, Fertility and sterility.

[34]  R. Norman,et al.  Adipokines: implications for female fertility and obesity. , 2005, Reproduction.

[35]  He-feng Huang,et al.  Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles. , 2005, Journal of Zhejiang University. Science. B.

[36]  Chia-Ing Li,et al.  Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. , 2005, Metabolism: clinical and experimental.

[37]  A. Pfeiffer,et al.  Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome , 2004 .

[38]  T. Saruta,et al.  Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[39]  V. Baker,et al.  Elective transfer of two embryos on day 3 in good prognosis patients reduces triplet rate without detectable compromise of pregnancy rate , 2004 .

[40]  J. Habbema,et al.  High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). , 2003, Human reproduction.

[41]  J. Chan,et al.  Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[42]  C. Mantzoros,et al.  Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.

[43]  M. Lazar,et al.  A family of tissue-specific resistin-like molecules. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. J. Rowe,et al.  WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple , 1993 .

[45]  Paul Poirier,et al.  Overview of epidemiology and contribution of obesity to cardiovascular disease. , 2014, Progress in cardiovascular diseases.

[46]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[47]  M. Olszanecka-Glinianowicz,et al.  Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[48]  Lu Xiu-e,et al.  Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles , 2008, Journal of Zhejiang University Science B.

[49]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[50]  K. Seow,et al.  Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. , 2004, Human reproduction.

[51]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[52]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..